Today’s Rating Alert: Is Diplomat Pharmacy (DPLO) Worth Your Time After Placed Credit Suisse’s Downgrade?

November 23, 2016 - By Louis Casey

Today's Rating Alert: Is Diplomat Pharmacy (DPLO) Worth Your Time After Placed Credit Suisse's Downgrade?

Diplomat Pharmacy (DPLO) Downgrade

Diplomat Pharmacy (DPLO) was cut by stock research analysts at Credit Suisse from a “Neutral” rating to a “Underperform” rating in analysts note issued to investors and clients on 23 November.

About 123,847 shares traded hands. Diplomat Pharmacy Inc (DPLO) has declined 52.17% since April 21, 2016 and is downtrending. It has underperformed by 57.50% the S&P500.

Insitutional Activity: The institutional sentiment increased to 1.82 in 2016 Q2. Its up 0.39, from 1.43 in 2016Q1. The ratio improved, as 17 funds sold all Diplomat Pharmacy Inc shares owned while 46 reduced positions. 23 funds bought stakes while 67 increased positions. They now own 50.07 million shares or 2.77% more from 48.72 million shares in 2016Q1.

The Louisiana-based Louisiana State Employees Retirement Sys has invested 0.03% in Diplomat Pharmacy Inc (NYSE:DPLO). Bridgeway Cap Management has 0.01% invested in the company for 15,400 shares. Raymond James Assoc, a Florida-based fund reported 31,352 shares. Moreover, Oberweis Asset Management has 2.47% invested in Diplomat Pharmacy Inc (NYSE:DPLO) for 237,515 shares. Ftb Advsr last reported 1,203 shares in the company. Denver Investment Advsr Lc reported 87,250 shares or 0.14% of all its holdings. Rnc Capital Management Ltd Limited Liability Company accumulated 0.26% or 79,452 shares. Blackrock, a New York-based fund reported 6,912 shares. Blackrock Gp Limited, a United Kingdom-based fund reported 46,115 shares. Parkside National Bank has 0% invested in the company for 71 shares. The New York-based Global X Management Ltd Liability has invested 0% in Diplomat Pharmacy Inc (NYSE:DPLO). Great West Life Assurance Can accumulated 0% or 3,400 shares. Pnc Financial Services Inc has invested 0% of its portfolio in Diplomat Pharmacy Inc (NYSE:DPLO). Teachers Retirement Of The State Of Kentucky owns 15,700 shares or 0.01% of their US portfolio. Meeder Asset Mngmt Incorporated has invested 0% of its portfolio in Diplomat Pharmacy Inc (NYSE:DPLO).

Insider Transactions: Since August 1, 2016, the stock had 0 insider buys, and 2 sales for $1.04 million net activity. On Thursday, September 15 Kaddis Atheer A sold $602,358 worth of the stock or 20,000 shares.

Diplomat Pharmacy, Inc. operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The company has a market cap of $931.52 million. The Company’s primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious and/or long-term conditions. It has a 29.23 P/E ratio. The Firm operates through specialty pharmacy services segment.

According to Zacks Investment Research, “Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat Pharmacy, Inc. is headquartered in Flint, Michigan.”

DPLO Company Profile

Diplomat Pharmacy, Inc. (Diplomat), incorporated on March 26, 1975, operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company’s primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious and/or long-term conditions. The Firm operates through specialty pharmacy services segment. The Firm provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Firm offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company’s specialty drug dispensing services include patient care coordination, clinical services, compliance and persistency programs, patient financial assistance, specialty pharmacy training/consulting (Diplomat University), benefits investigation, prior authorization and risk evaluation and medication strategy (REMS).

More notable recent Diplomat Pharmacy Inc (NYSE:DPLO) news were published by: Businesswire.com which released: “DPLO LOSS ALERT: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of …” on November 17, 2016, also Fool.com with their article: “Why Diplomat Pharmacy, Inc. Is Plunging Today” published on November 03, 2016, Prnewswire.com published: “Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Diplomat Pharmacy …” on November 16, 2016. More interesting news about Diplomat Pharmacy Inc (NYSE:DPLO) were released by: Fool.com and their article: “Why Diplomat Pharmacy, Inc. Shares Are Falling 13.6% Today” published on October 26, 2016 as well as Finance.Yahoo.com‘s news article titled: “Lawsuit for Investors in shares of Diplomat Pharmacy Inc (DPLO) announced by …” with publication date: November 16, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>